Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Fudin

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 9, 2006
Blowing the whistle: a pharmacist's vexing experience unraveledJeffrey Fudin
American Journal of Nephrology|May 20, 2020
Analgesic Polypharmacy Is a Likely Link to Increased Hospital AdmissionsJeffrey Fudin, Amelia Persico
Pain and Therapy|January 30, 2020
A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic PainJeffrey Gudin, Jeffrey Fudin
Pain Medicine (Malden, Mass.)|July 26, 2014
Potential cost-shifting and hidden costs and risks in the economic analysis of opioid abuse-deterrent formulationsRobert Twillman, Jeffrey Fudin
Journal of Pain Research|March 12, 2020
Peripheral Opioid Receptor Antagonists for Opioid-Induced Constipation: A Primer on Pharmacokinetic Variabilities with a Focus on Drug InteractionsJeffrey Gudin, Jeffrey Fudin
Physical Medicine and Rehabilitation Clinics of North America|April 14, 2020
Nonsteroidal Antiinflammatory Drugs for Acute and Chronic PainTimothy J Atkinson, Jeffrey Fudin
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 21, 2010
Maximum daily dose of hydrocodoneDana M Nerenberg, Jeffrey Fudin
Pain Medicine (Malden, Mass.)|January 16, 2014
Opioid prescribing levels off, but is less really more?Jeffrey Fudin, Timothy J Atkinson
Medicine Access @ Point of Care|October 7, 2022
Amid COVID-19 crisis, pain therapeutics telehealth services by pharmacist clinicians fill unique void and mitigate riskJeffrey Bettinger, Jacqueline Cleary, Jeffrey Fudin
Postgraduate Medicine|December 5, 2015
Levorphanol use: past, present and futureJeffrey Gudin, Jeffrey Fudin, Srinivas Nalamachu
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 9, 2006
Blowing the whistle: a pharmacist's vexing experience unraveledJeffrey Fudin
American Journal of Nephrology|May 20, 2020
Analgesic Polypharmacy Is a Likely Link to Increased Hospital AdmissionsJeffrey Fudin, Amelia Persico
Pain and Therapy|January 30, 2020
A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic PainJeffrey Gudin, Jeffrey Fudin
Pain Medicine (Malden, Mass.)|July 26, 2014
Potential cost-shifting and hidden costs and risks in the economic analysis of opioid abuse-deterrent formulationsRobert Twillman, Jeffrey Fudin
Journal of Pain Research|March 12, 2020
Peripheral Opioid Receptor Antagonists for Opioid-Induced Constipation: A Primer on Pharmacokinetic Variabilities with a Focus on Drug InteractionsJeffrey Gudin, Jeffrey Fudin
Physical Medicine and Rehabilitation Clinics of North America|April 14, 2020
Nonsteroidal Antiinflammatory Drugs for Acute and Chronic PainTimothy J Atkinson, Jeffrey Fudin
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 21, 2010
Maximum daily dose of hydrocodoneDana M Nerenberg, Jeffrey Fudin
Pain Medicine (Malden, Mass.)|January 16, 2014
Opioid prescribing levels off, but is less really more?Jeffrey Fudin, Timothy J Atkinson
Medicine Access @ Point of Care|October 7, 2022
Amid COVID-19 crisis, pain therapeutics telehealth services by pharmacist clinicians fill unique void and mitigate riskJeffrey Bettinger, Jacqueline Cleary, Jeffrey Fudin
Postgraduate Medicine|December 5, 2015
Levorphanol use: past, present and futureJeffrey Gudin, Jeffrey Fudin, Srinivas Nalamachu
Pageof 7